The Quarterly Earnings Report in the Aug. 9, 1995issue of BioWorld Today should have reported thatGeneMedicine Inc., had $18.1 million in cash and 8.4million shares outstanding on June 30.

(c) 1997 American Health Consultants. All rights reserved.